Targeted Medical Pharma, Inc. 4/A
4/A · Targeted Medical Pharma, Inc. · Filed Sep 4, 2013
Insider Transaction Report
Form 4/AAmended
Shell William
DirectorCEO/Chief Scientific Officer10% Owner
Transactions
- Purchase
Common Stock, $.001 par value per share
2013-06-20$1.15/sh+28,100$32,315→ 651,054 total(indirect: By Trust)
Holdings
- 622,954(indirect: By Trust)
Common Stock, $.001 par value per share
Footnotes (3)
- [F1]Common stock and warrants are held by Willliam Shell Survivor's Trust.
- [F2]On July 23, 2013, the reporting person mistakenly filed a Form 4 without including his purchase of 28,100 shares of Targeted Medical Pharma, Inc. Such purchase occurred on June 20, 2013 at a weighted average price of $1.15 per share. These shares were purchased in multiple transactions at prices ranging from $1.00 to $1.20 per share.
- [F3]See Remarks